Scholarlink

<p>Pericarditis is an inflammatory disease that affects the pericardial sac surrounding the heart. Although usually benign, recurrence is a common complication, and pericarditis may lead to cardiac tamponade or constrictive pericarditis. Non-steroidal anti-inflammatory drugs, with adjunctive colchicine, are the cornerstone of pericarditis treatment. Glucocorticoids should be used with caution. Interleukin-1 blockers anakinra and rilonacept have demonstrated efficacy in reducing pericarditis recurrence rates. Ongoing trials with alternative treatments (e.g. goflikicept, cannabidiol) are showing promise, and new treatment options should be supported by further investigation of pericarditis pathophysiology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Treat acute or recurrent pericarditis with anti-inflammatory drugs before considering newer treatments

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月17日

查看全文
  • Aisling McGuigan

摘要

Pericarditis is an inflammatory disease that affects the pericardial sac surrounding the heart. Although usually benign, recurrence is a common complication, and pericarditis may lead to cardiac tamponade or constrictive pericarditis. Non-steroidal anti-inflammatory drugs, with adjunctive colchicine, are the cornerstone of pericarditis treatment. Glucocorticoids should be used with caution. Interleukin-1 blockers anakinra and rilonacept have demonstrated efficacy in reducing pericarditis recurrence rates. Ongoing trials with alternative treatments (e.g. goflikicept, cannabidiol) are showing promise, and new treatment options should be supported by further investigation of pericarditis pathophysiology.